ArticleCancer medicine2025

Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple Myeloma.

Jessie Sutphin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.